Medifast reports Q3 2026 loss, coach decline and sets Q4 profitability target
+2 new sources since this summary was written
Medifast announced third‑quarter 2026 results showing revenue of $72.05 million, down 19.4% year‑over‑year, and a net loss of $17.5 million. The number of independent active earning coaches fell 47.7% to 10,200, while revenue per coach rose 54% to $7,064. The company guided fourth‑quarter revenue of $55 million‑$75 million and EPS of $0‑$0.25, reiterating its aim to achieve profitability in Q4.
Why it matters
The Q4 revenue and EPS guidance suggest a possible return to profitability, which could improve cash flow and support the ongoing Trilivy transformation (the company says the guidance “targets profitability in Q4”). The strong balance sheet of $172.5 million cash and no debt gives the firm flexibility to fund the rollout and cost‑reduction initiatives (the company notes its debt‑free position provides a stable base).
Key facts
- 1Q3 2026 revenue was $72.05 million, a 19.4% decline year‑over‑year. seekingalpha.com
- 2The company posted a net loss of $17.5 million for the quarter. tradingview.com
- 3Adjusted loss per diluted share was $0.19. stocktitan.net
- 4Active earning coaches fell 47.7% to 10,200. stocktitan.net
- 5Revenue per active earning coach increased 54% year‑over‑year to $7,064. investing.com
- 6Cash, cash equivalents and investment securities totaled $172.5 million with no debt. stocktitan.net
Summary written by AlphAI AI Desk from 15 of 15 sources. Not investment advice. Figures are as stated by the linked sources.